BeOne Medicines Ltd. (ONC) revenue & profit
BeOne Medicines Ltd. (ONC): revenue $5.3B, net income $286.9M in 2025; latest quarter +29.6% year over year. From SEC filings.
$5.3BRevenue 2025
TickerONC (Nasdaq)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$5.3B
Net income 2025$286.9M
Net margin5.4%
Annual revenue growth+40.2%
Latest quarter (2026 Q2) · Revenue$1.7B
vs. same quarter last year+29.6%
Latest quarter · Net income$237M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $1.4B | -$2B | |
| 2023 | $2.5B | -$881.7M | |
| 2024 | $3.8B | -$644.8M | |
| 2025 | $5.3B | $286.9M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.